SCHEMBL28057794

SCHEMBL28057794

CN(Cc1ccccc1)S(=O)(=O)c1sc(C(=O)C(C)(C)C)c(C(N)=O)c1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
HDAC4 P56524 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
ALDH1A1 P00352 6/20 0.42
MAPT P10636 6/20 0.41
HPGD P15428 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
USP2 O75604 1/20 0.41
ALOX15 P16050 1/20 0.41
RECQL P46063 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CFTR P13569 1/20 0.40
LMNA P02545 4/20 0.39
RXFP1 Q9HBX9 3/20 0.39
CNR2 P34972 1/20 0.38
HTT P42858 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
THRB P10828 1/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28156735 0.81 HDAC4 (0.43) MEN1KMT2AHDAC4HDAC6ALDH1A1
SCHEMBL28057781 0.69 CFTR (0.45) MEN1KMT2AALDH1A1MAPTCFTR
SCHEMBL28057682 0.68 ABCC9 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL16338655 0.67 CFTR (0.67) MEN1KMT2AHDAC4HDAC6ALDH1A1
SCHEMBL4778320 0.66 KMT2A (0.47) MEN1KMT2AHDAC4HDAC6ALDH1A1
SCHEMBL1135577 0.65 LMNA (0.46) MEN1KMT2AHDAC4HDAC6ALDH1A1
SCHEMBL12261100 0.65 KMT2A (0.52) MEN1KMT2AHDAC4HDAC6ALDH1A1
SCHEMBL4876765 0.64 KMT2A (0.52) MEN1KMT2AHDAC4HDAC6ALDH1A1
SCHEMBL18080771 0.64 KMT2A (0.62) MEN1KMT2AHDAC4HDAC6ALDH1A1
SCHEMBL28057649 0.64 LMNA (0.39) MEN1KMT2AALDH1A1MAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105531268-A Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis GALAPAGOS NV 2016-04-27 CN disclosed